Table 3.
Distributions of VDR (FokI, BsmI, ApaI, and TaqI) gene polymorphisms in patients with CSU (n = 90) and controls (n = 90)
| VDR gene | Patients with CSU n (%) | Controls n (%) | OR (95% CI) | χ2 | P-value |
|---|---|---|---|---|---|
| FokI (rs2228570): | |||||
| TT | 19 (21.1) | 28 (31.1) | 5.232 | 0.073 | |
| TC | 39 (43.3) | 43 (47.8) | |||
| CC | 32 (35.6) | 19 (21.1) | |||
| T | 77 (42.8) | 99 (55) | 5.380 | ||
| C | 103 (57.2) | 81 (45) | 0.612 (0.403–0.928) | 0.020 | |
| BsmI (rs1544410): | |||||
| GG | 83 (92.2) | 79 (87.8) | 2.468 | 0.308 | |
| GA | 6 (6.7) | 11 (12.2) | |||
| AA | 1 (1.1) | 0 (0) | |||
| G | 172 (95.5) | 169 (93.9) | |||
| A | 8 (4.4) | 11 (6.1) | 1.399 (0.549–3.565) | 0.5 | 0.479 |
| ApaI (rs7975232): | |||||
| CC | 50 (55.6) | 56 (62.2) | 0.892 | 0.640 | |
| CA | 32 (35.6) | 28 (31.1) | |||
| AA | 8 (8.9) | 6 (6.7) | |||
| C | 132 (73.3) | 140 (77.8) | |||
| A | 48 (26.7) | 40 (22.2) | 0.786 (0.485–1.273) | 0.963 | 0.327 |
| TaqI (rs731236): | |||||
| TT | 83 (92.2) | 77 (85.6) | 3.685 | 0.144 | |
| TC | 6 (6.7) | 13 (14.4) | |||
| CC | 1 (1.1) | 0 (0) | |||
| T | 172 (95.6) | 167 (92.8) | |||
| C | 8 (4.4) | 13 (7.2) | 1.674 (0.676–4.142) | 1.264 | 0.261 |